Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 4/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16922196 | 1.00 | GSK3B (0.42) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL28761849 | 0.87 | HDAC3 (0.41) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL1259362 | 0.84 | GSK3B (0.40) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL12602855 | 0.81 | GSK3B (0.46) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL19328352 | 0.81 | KMT2A (0.47) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL8311841 | 0.80 | ALDH1A1 (0.40) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL3110619 | 0.77 | GSK3B (0.48) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL12593806 | 0.77 | TDP1 (0.47) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL4937398 | 0.74 | SLC6A3 (0.54) | GSK3BALDH1A1LMNACES2CES1 | |
| SCHEMBL4938257 | 0.74 | SLC6A3 (0.54) | GSK3BALDH1A1LMNACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080262025-A1 | Processes for the Preparation of Zolpidem and its Hemitartrate | RANBAXY LABORATORIES LIMITED (IN) | 2008-10-23 | — | — | US | disclosed |
| US-20080262025-A1 | Processes for the Preparation of Zolpidem and its Hemitartrate | RANBAXY LABORATORIES LIMITED (IN) | 2008-10-23 | — | — | US | disclosed |
| US-20080262025-A1 | Processes for the Preparation of Zolpidem and its Hemitartrate | RANBAXY LABORATORIES LIMITED (IN) | 2008-10-23 | — | — | US | disclosed |
| US-20080262025-A1 | Processes for the Preparation of Zolpidem and its Hemitartrate | RANBAXY LABORATORIES LIMITED (IN) | 2008-10-23 | — | — | US | disclosed |
| WO-2006008636-A3 | PROCESSES FOR THE PREPARATION OF ZOLPIDEM AND ITS HEMITARTRATE | RANBAXY LAB LTD (IN) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006008636-A2 | PROCESSES FOR THE PREPARATION OF ZOLPIDEM AND ITS HEMITARTRATE | RANBAXY LABORATORIES LIMITED (IN) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006008636-A2 | PROCESSES FOR THE PREPARATION OF ZOLPIDEM AND ITS HEMITARTRATE | RANBAXY LABORATORIES LIMITED (IN) | 2006-01-26 | — | — | WO | disclosed |
| WO-2005010002-A1 | PROCESS FOR THE SYNTHESIS OF ZOLPIDEM | RANBAXY LABORATORIES LIMITED (IN) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262025-A1 | Processes for the Preparation of Zolpidem and its Hemitartrate | HTR5A, GABRA5, HTR4 | GSK3B 684/4885ALDH1A1 2589/4885LMNA 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.